National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting, 32169-32170 [E9-15847]
Download as PDF
<![CDATA[
32169
Federal Register / Vol. 74, No. 128 / Tuesday, July 7, 2009 / Notices
the impact of each of the programs. The
evaluation tools are primarily protocols
for conducting interviews with various
staff of the three programs and
stakeholders associated with the
programs. The interview protocols were
tested during a pilot study in 2008.
There is also a self-administered form
for each of the programs to be
completed by Executive Directors or
his/her designee. The self-administered
form was developed as a result of the
pilot study and, therefore, has not been
tested for reliability and validity. It is
intended that the clearance process will
be a mechanism for determining the
reliability, validity, and feasibility of
using this instrument.
Respondents: Staff of State Councils
on Developmental Disabilities, State
Protection and Advocacy Systems for
Individuals with developmental
disabilities, and University Centers for
Excellence in Developmental
Disabilities, Education, Research, and
Service; individuals with
developmental disabilities; parents of
individuals with developmental
disabilities; siblings of individuals with
developmental disabilities; guardians;
advocates; policymakers; service
providers; university faculty; and others
(e.g., DDC chairs, members of Protection
and Advocacy boards of directors or
commissioners; Consumer Advisory
Committee members)
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
DD Council: Executive Director Interview ......................................................
DD Council: Interview with Council Chair/Council Members ........................
DD Council: Group Interview with Policymakers, Collaborators, and Grantees ..............................................................................................................
UCEDD: Telephone Interview with Current and Graduated Students ..........
UCEDD: Interview with the Consumer Advisory Committee .........................
UCEDD: Interview with Peer Researchers and Colleagues .........................
UCEDD: Interview with Recipients of Community Services or Members of
Organizations/Agencies that Are Trained To Provide Community Services .............................................................................................................
UCEDD: Self-administered Form ...................................................................
P&A: Executive Director Interview .................................................................
P&A: Staff Interview .......................................................................................
P&A: Board of Directors (Commissioners)—Chair and Members ................
P&A: Group Interview with Policymakers and Collaborators ........................
P&A: Interview with Recipient of Community Education ...............................
P&A: Interview with Clients ...........................................................................
P&A: Self-administered Form ........................................................................
UCEDD: Interview with Director ....................................................................
DD Council: Group Interview with Recipients of Self-Advocacy and Leadership Education and Training ...................................................................
DD Council: Group Interview with Recipients of Education and Training to
Improve Community Capacity ....................................................................
DD Council: Self-administered Form .............................................................
DD Council Estimate of Total Burden Hours for Activities to Support Administration of Proposed Information Collection Instruments ....................
P&A Estimate of Total Burden Hours for Activities to Support Administration of Proposed Information Collection Instruments .................................
UCEDD Estimate of Total Burden Hours for Activities to Support Administration of Proposed Information Collection Instruments .............................
Estimated Total Annual Burden
Hours: 4,075.
Additional Information:
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment:
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
VerDate Nov<24>2008
14:45 Jul 06, 2009
Jkt 217001
Number of
responses per
respondent
1
1
4
0.75
80
45
160
100
60
100
1
1
1
1
2
0.75
0.75
0.75
320
75
45
75
100
20
20
60
60
160
100
100
20
20
1
1
1
1
1
1
1
1
1
1
0.75
8
4
0.75
0.75
2
0.75
0.75
8
4
75
160
80
45
45
320
75
75
160
80
100
1
0.75
75
100
20
1
1
0.75
8
75
160
20
1
33.50
670
20
1
33.50
670
20
1
33.50
670
Dated: June 30, 2009.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E9–15841 Filed 7–6–09; 8:45 am]
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Total burden
hours
20
60
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following:
Office of Management and Budget,
Paperwork Reduction Project, Fax: 202–
395–7245, Attn: Desk Officer for the
Administration for Children and
Families.
BILLING CODE 4184–01–P
Average
burden hours
per response
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\07JYN1.SGM
07JYN1
32170
Federal Register / Vol. 74, No. 128 / Tuesday, July 7, 2009 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism. Special
Emphasis Panel Alcohol Pharmacotherapy
and the Treatment and Prevention of HIV/
AIDS. (RFA AA 09 007/008) and Other AIDS
Related Research.
Date: August 6, 2009.
Time: 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Katrina L Foster, PhD,
Scientific Review Officer, National Inst on
Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm.
2019, Rockville, MD 20852. 301–443–4032.
katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: June 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–15847 Filed 7–6–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences. Special Emphasis
Panel Minority Biomedical Research
Support.
VerDate Nov<24>2008
14:45 Jul 06, 2009
Jkt 217001
Date: July 19–20, 2009.
Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Margaret J. Weidman, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18B, Bethesda, MD
20892. 301–594–3663.
weidmanma@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences. Special Emphasis
Panel MBRS Score.
Date: July 20–21, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Lisa Dunbar, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda, MD
20892. 301–594–2849. dunbarl@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences. Special Emphasis
Panel New Innovator Awards.
Date: July 21, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Richard T. Okita, PhD,
Program Director, Pharmacological and
Physiological Sciences Branch, National
Institute of General Medical Sciences,
National Institutes of Health, Natcher
Building, Room 2A5–49, Bethesda, MD
20892. 301–594–4469. okitar@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Guidelines for Human Stem Cell
Research’’ (Guidelines).
On March 9, 2009, President Barack
H. Obama issued Executive Order
13505: Removing Barriers to
Responsible Scientific Research
Involving Human Stem Cells. The
Executive Order states that the Secretary
of Health and Human Services, through
the Director of NIH, may support and
conduct responsible, scientifically
worthy human stem cell research,
including human embryonic stem cell
(hESC) research, to the extent permitted
by law.
These Guidelines implement
Executive Order 13505, as it pertains to
extramural NIH-funded stem cell
research, establish policy and
procedures under which the NIH will
fund such research, and helps ensure
that NIH-funded research in this area is
ethically responsible, scientifically
worthy, and conducted in accordance
with applicable law. Internal NIH
policies and procedures, consistent with
Executive Order 13505 and these
Guidelines, will govern the conduct of
intramural NIH stem cell research.
DATES: Effective Date: These Guidelines
are effective on July 7, 2009.
Summary of Public Comments on
Draft Guidelines: On April 23, 2009 the
NIH published draft Guidelines for
research involving hESCs in the Federal
Register for public comment, 74 FR
18578 (April 23, 2009). The comment
period ended on May 26, 2009.
The NIH received approximately
49,000 comments from patient advocacy
groups, scientists and scientific
societies, academic institutions, medical
organizations, religious organizations,
and private citizens. The NIH also
received comments from members of
Congress. This Notice presents the final
Guidelines together with the NIH
response to public comments that
addressed provisions of the Guidelines.
Dated: June 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–15846 Filed 7–6–09; 8:45 am]
Title of the Guidelines, Terminology,
and Background
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health Guidelines
for Human Stem Cell Research
SUMMARY: The National Institutes of
Health (NIH) is hereby publishing final
‘‘National Institutes of Health
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Respondents felt the title of the NIH
draft guidelines was misleading, in that
it is entitled ‘‘National Institutes of
Health Guidelines for Human Stem Cell
Research,’’ yet addresses only one type
of human stem cell. The NIH notes that
although the Guidelines pertain
primarily to the donation of embryos for
the derivation of hESCs, one Section
also applies to certain uses of both
hESCs and human induced pluripotent
stem cells. Also, the Guidelines discuss
applicable regulatory standards when
research involving human adult stem
cells or induced pluripotent stem cells
constitutes human subject research.
E:\FR\FM\07JYN1.SGM
07JYN1
]]>Agencies
[Federal Register Volume 74, Number 128 (Tuesday, July 7, 2009)]
[Notices]
[Pages 32169-32170]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15847]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 32170]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism. Special Emphasis Panel Alcohol Pharmacotherapy and the
Treatment and Prevention of HIV/AIDS. (RFA AA 09 007/008) and Other
AIDS Related Research.
Date: August 6, 2009.
Time: 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Katrina L Foster, PhD, Scientific Review
Officer, National Inst on Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm. 2019, Rockville, MD
20852. 301-443-4032. katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: June 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15847 Filed 7-6-09; 8:45 am]
BILLING CODE 4140-01-M
